Evidence map›Paper›PMID 27749823›Full record

ArticleNature cell biology2016

Regulation of transcriptional elongation in pluripotency and cell differentiation by the PHD-finger protein Phf5a.

Alexandros Strikoudis, Charalampos Lazaris, Thomas Trimarchi, Antonio L Galvao Neto, Yan Yang, Panagiotis Ntziachristos, Scott Rothbart, Shannon Buckley, Igor Dolgalev, Matthias Stadtfeld and 4 more

Abstract read
In one paragraph

Article in Nature cell biology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 49 papers.

0numbers the graph read from it
0cells of the map it votes in
49citing papers in PubMed
3.8field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

49 citing papers in PubMed, 86 citations in OpenAlex.

  1. The hidden players: LncRNA-Encoded micropeptides in cancer hallmarks.Cellular and molecular life sciences : CMLS · 2026
    Review
  2. Review
  3. RNA-binding proteins connect Exon usage to the chromatin.NAR genomics and bioinformatics · 2025
    Article
  4. Article
  5. Article
  6. The Epigenetic Reader PHF23 Is Required for Embryonic Neurogenesis.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2025
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. The regulation of transcription elongation in embryonic stem cells.Frontiers in cell and developmental biology · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 1 country.

Alexandros StrikoudisDepartment of Pathology, NYU School of Medicine, New York, New York 10016, USA.
Charalampos LazarisDepartment of Pathology, NYU School of Medicine, New York, New York 10016, USA.ORCID http://orcid.org/0000-0002-7345-8288
Thomas TrimarchiDepartment of Pathology, NYU School of Medicine, New York, New York 10016, USA.
Antonio L Galvao NetoDepartment of Pathology, NYU School of Medicine, New York, New York 10016, USA.
Yan YangDepartment of Pathology, NYU School of Medicine, New York, New York 10016, USA.
Panagiotis NtziachristosDepartment of Pathology, NYU School of Medicine, New York, New York 10016, USA.
Scott RothbartDepartment of Biochemistry and Biophysics and Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, North Carolina 27599, USA.
Shannon BuckleyDepartment of Pathology, NYU School of Medicine, New York, New York 10016, USA.
Igor DolgalevDepartment of Pathology, NYU School of Medicine, New York, New York 10016, USA.ORCID http://orcid.org/0000-0003-4451-126X
Matthias StadtfeldHelen L. &Martin S. Kimmel Center for Stem Cell Biology, NYU School of Medicine, New York, New York 10016, USA.
Brian D StrahlDepartment of Biochemistry and Biophysics and Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, North Carolina 27599, USA.
Brian D DynlachtDepartment of Pathology, NYU School of Medicine, New York, New York 10016, USA.
Aristotelis TsirigosDepartment of Pathology, NYU School of Medicine, New York, New York 10016, USA.
Iannis AifantisDepartment of Pathology, NYU School of Medicine, New York, New York 10016, USA.
New York University · USNYU Langone’s Laura and Isaac Perlmutter Cancer CenterUniversity of North Carolina at Chapel Hill · USNew York Genome Center · US

Funding

Virology Research Program (Program 4)P30CA016086 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Deborah F. Tate · 1985 to 2026
$201.5M
Vaccine FacilityP30CA016087 · NCI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI ADRIANA HEGUY · 1985 to 2026
$83.1M
Role of TET2 mutations in malignant transformation and acute myeloid leukemiaR01CA173636 · NCI · SLOAN-KETTERING INST CAN RESEARCH · PI AIFANTIS, IANNIS, LEVINE, ROSS L · 2013 to 2022
$6.3M
Role of the pRB family in Quiescence and DifferentiationR01GM067132 · NIGMS · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI DYNLACHT, BRIAN D · 2003 to 2015
$4.7M
The role of the SCF/FBW7 ubiquitin ligase complex in hematopiesis and leukemia.R01CA133379 · NCI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI AIFANTIS, IANNIS · 2009 to 2018
$3.6M
Regulation of hematopoietic stem cell differentiationR01CA105129 · NCI · UNIVERSITY OF CHICAGO · PI AIFANTIS, IANNIS · 2005 to 2014
$2.8M
Long non-coding RNAs in hematopoiesis and blood malignancyR01CA194923 · NCI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI AIFANTIS, IANNIS · 2015 to 2019
$2.3M
Mechanisms of T cell leukemia induction and maintenanceR01CA149655 · NCI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI AIFANTIS, IANNIS · 2010 to 2015
$2.0M
Maintenance of epigenetic integrity during nuclear reprogrammingR01GM111852 · NIGMS · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI STADTFELD, MATTHIAS · 2014 to 2018
$1.6M
Exploring a new therapeutic approach through targeting epigenetic enzymes in ALLR00CA188293 · NCI · NORTHWESTERN UNIVERSITY AT CHICAGO · PI NTZIACHRISTOS, PANAGIOTIS · 2015 to 2017
$747k
Mechanisms Regulating DNA Methylation Maintenance in ChromatinR00CA181343 · NCI · VAN ANDEL RESEARCH INSTITUTE · PI ROTHBART, SCOTT · 2015 to 2017
$746k
NCI NIH HHS P30 CA016086NCI NIH HHS P30 CA016087NCI NIH HHS R00 CA181343NCI NIH HHS R00 CA188293NCI NIH HHS R01 CA105129NCI NIH HHS R01 CA133379NCI NIH HHS R01 CA149655NCI NIH HHS R01 CA173636NCI NIH HHS R01 CA194923NIGMS NIH HHS R01 GM067132NIGMS NIH HHS R01 GM111852
6 · The paper itself

Abstract

Pluripotent embryonic stem cells (ESCs) self-renew or differentiate into all tissues of the developing embryo and cell-specification factors are necessary to balance gene expression. Here we delineate the function of the PHD-finger protein 5a (Phf5a) in ESC self-renewal and ascribe its role in regulating pluripotency, cellular reprogramming and myoblast specification. We demonstrate that Phf5a is essential for maintaining pluripotency, since depleted ESCs exhibit hallmarks of differentiation. Mechanistically, we attribute Phf5a function to the stabilization of the Paf1 transcriptional complex and control of RNA polymerase II elongation on pluripotency loci. Apart from an ESC-specific factor, we demonstrate that Phf5a controls differentiation of adult myoblasts. Our findings suggest a potent mode of regulation by Phf5a in stem cells, which directs their transcriptional programme, ultimately regulating maintenance of pluripotency and cellular reprogramming.

Indexed as

Transcription, GeneticAgingAnimalsCarrier ProteinsCell DifferentiationCell LineCell ProliferationCellular ReprogrammingDNA-Binding ProteinsEmbryonic DevelopmentGene Expression Regulation, DevelopmentalMiceMice, Inbred C57BLMouse Embryonic Stem CellsMyoblastsPluripotent Stem CellsCarrier ProteinsDNA-Binding ProteinsPhf5a protein, mouseRNA-Binding ProteinsTrans-Activators

Identifiers

PMID27749823
PMCPMC5083132
OpenAlexW2538304990

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.